Published August 20, 2019 | Version v1
Patent Open

Treatment with opioid antagonists and mTOR inhibitors

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Embodiments of the invention provide methods of treating a disorder or disease characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a μ-opioid receptor antagonist.

Files

US10383869.pdf

Files (2.2 MB)

Name Size Download all
md5:fbef2d0836e214497d04554201b3407f
2.2 MB Preview Download

Additional details

Identifiers

Patent number
US 10383869 B2
Patent application number
US 201615353099 A
Other
oai:uchicago.tind.io:6992

Dates

Patent filed
2016-11-16

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care